Yuyu Pharma Inc Working Capital to Net Assets Ratio
Yuyu Pharma Inc working capital to net assets ratio. Yuyu Pharma Inc (000227) has a Working Capital to Net Assets ratio of 30.1% as of September 2025. Working capital of ₩41.91 Billion (current assets of ₩96.67 Billion minus current liabilities of ₩54.76 Billion) is measured against net assets of ₩139.10 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Yuyu Pharma Inc (2014–2024)
Working capital to net assets ratio of Yuyu Pharma Inc from 2014 to 2024. This chart shows how Yuyu Pharma Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 30.1%, reflecting working capital of ₩41.91 Billion against net assets of ₩139.10 Billion KRW. Explore investment intensity of Yuyu Pharma Inc to see how much of total assets are deployed in long-term investments.
Yuyu Pharma Inc Working Capital to Net Assets Ratio by Year (2014–2024)
Yuyu Pharma Inc working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Yuyu Pharma Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Yuyu Pharma Inc asset portfolio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 27.7% | ₩37.47 Billion | ₩135.06 Billion | ₩101.95 Billion | ₩64.48 Billion | ▼ -15.1 pp |
| 2023 | 42.9% | ₩51.62 Billion | ₩120.36 Billion | ₩101.60 Billion | ₩49.98 Billion | ▲ +16.9 pp |
| 2022 | 26.0% | ₩32.04 Billion | ₩123.37 Billion | ₩96.36 Billion | ₩64.32 Billion | ▼ -27.5 pp |
| 2021 | 53.5% | ₩68.87 Billion | ₩128.69 Billion | ₩98.89 Billion | ₩30.01 Billion | ▲ +14.2 pp |
| 2020 | 39.4% | ₩46.07 Billion | ₩117.04 Billion | ₩64.47 Billion | ₩18.40 Billion | ▲ +14.4 pp |
| 2019 | 24.9% | ₩22.56 Billion | ₩90.54 Billion | ₩65.05 Billion | ₩42.50 Billion | ▼ -22.4 pp |
| 2018 | 47.3% | ₩41.08 Billion | ₩86.87 Billion | ₩68.87 Billion | ₩27.79 Billion | ▲ +13.5 pp |
| 2017 | 33.8% | ₩27.99 Billion | ₩82.83 Billion | ₩63.47 Billion | ₩35.48 Billion | ▲ +1.3 pp |
| 2016 | 32.5% | ₩25.45 Billion | ₩78.29 Billion | ₩56.64 Billion | ₩31.19 Billion | ▲ +5.6 pp |
| 2015 | 26.9% | ₩19.81 Billion | ₩73.73 Billion | ₩49.02 Billion | ₩29.21 Billion | ▼ -4.8 pp |
| 2014 | 31.7% | ₩22.67 Billion | ₩71.49 Billion | ₩45.57 Billion | ₩22.90 Billion | — |